Alto Neuroscience

Meet Mike Hanley, COO here at Alto. Mike leads new product planning, portfolio strategy, and cross-functional teams to maximize the impact of the Company’s clinical-stage programs and biomarker platform. When he's not problem-solving, you'll likely find him watching sports, preferably college football! #MeetTheTeam

This year, #WorldMentalHealthDay is focused on prioritizing #MentalHealth in the workplace. At Alto, we are passionate about granting our team members the space to care for their mental health so that we can work together as one. Learn more about #WMHD2024 here: https://bit.ly/3BE5kCf

1 in 5 adults in the U.S. experience mental illness each year. This #MentalIllnessAwarenessWeek, we’re committed to redefining #psychiatry with #PrecisionMedicine. At Alto, we believe in tailored treatments for every individual, providing access through decentralized #ClinicalTrials, and supporting better mental health for all. Learn more from NAMI about how you can get involved: https://lnkd.in/erd3HWWM

Meet Sarah Long, Ph.D., a Senior R&D Engineer here at Alto. When Sarah isn’t in the Mountain View office project planning, coding, analyzing data, product testing, or designing, she can likely be found cooking, painting, reading, playing pickleball, or mountain biking. 🚴 #MeetTheTeam

🔥 Our CEO, Amit Etkin, will participate in a fireside chat at the Cowen Inc. 4th Annual Novel Mechanisms in Neuropsychiatry Summit. conference. Access the webcast here: https://bit.ly/47cFfII

Our CEO, Amit Etkin will join Nikolaos Mellios, M.D., Ph.D. and Chia-Yen Chen, Sc.D. in a panel discussion of precision therapeutics at the 4th Annual Conference on Precision Psychiatry, presented by Massachusetts General Hospital. We look forward to discussing #PrecisionPsychiatry with physicians and fellow industry leaders. Learn more about the conference here: https://bit.ly/47eR6pC

Our team will be attending the 37th ECNP Congress! We're eager to connect with leading experts in #psychiatry and #neuropsychiatry to collaborate and share insights that drive innovation in #Psychiatric care. More info here: https://bit.ly/4dV9DK7 #ECNP2024 European College of Neuropsychopharmacology (ECNP)

In case you missed it, our leadership team and Dr. Gerard Sanacora shared the latest on #PrecisionPsychiatry at our recent Investor Day. The event focused on our upcoming ALTO-100 Phase 2b data readout in #MajorDepressiveDisorder. Watch the recording here: https://bit.ly/3MWzfdz

At the Cantor Fitzgerald Annual Healthcare Conference, our CEO Amit Etkin will share corporate highlights and information on our #PrecisionPsychiatry approach. #CantorHCC More here: https://bit.ly/3ThaJr8

Next week, our CEO Amit Etkin will participate in a panel discussion at the Foundation for the National Institutes of Health's #TeamScienceDay2024. The panel will focus on decoding depression and predicting outcomes in #MentalHealth. More info here: https://bit.ly/4gdF18g #BridgesToBreakthroughs